NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
+0.68%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$788M
AUM Growth
-$35.9M
(-4.4%)
Cap. Flow
+$36.1M
Cap. Flow
% of AUM
4.58%
Top 10 Holdings %
Top 10 Hldgs %
45.27%
Holding
137
New
21
Increased
29
Reduced
37
Closed
17
Top Buys
| 1 |
Assertio
ASRT
|
$12M |
| 2 |
America's Car Mart
CRMT
|
$11.4M |
| 3 |
Zevra Therapeutics
ZVRA
|
$11.1M |
| 4 |
Peloton Interactive
PTON
|
$9.05M |
| 5 |
Neuropace
NPCE
|
$7.74M |
Top Sells
| 1 |
The Bancorp
TBBK
|
$13.2M |
| 2 |
AUTL
Autolus Therapeutics
AUTL
|
$10.2M |
| 3 |
Pathward Financial
CASH
|
$7.8M |
| 4 |
Soleno Therapeutics
SLNO
|
$7.6M |
| 5 |
MediaAlpha
MAX
|
$7.51M |
Sector Composition
| 1 | Healthcare | 53.65% |
| 2 | Consumer Discretionary | 13.83% |
| 3 | Financials | 9.32% |
| 4 | Communication Services | 8.18% |
| 5 | Technology | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Noodles & Co
NDLS
$31.1M
| $8.6M | 0.73% |
3,495,827
+2,495,827
| +250% | +$6.14M |
|
27
MillerKnoll
MLKN
$1.47B
| $8.32M | 0.71% |
340,228
-267,655
| -44% | -$6.54M |
|
28
Tourmaline Bio
TRML
$687M
| $8.3M | 0.71% |
295,313
+150,310
| +104% | +$4.22M |
|
29
DHI Group
DHX
$143M
| $8.26M | 0.71% |
2,698,201
-331,997
| -11% | -$1.02M |
|
30
DarioHealth
DRIO
$23M
| $7.92M | 0.68% |
120,710
-215
| -0.2% | -$14.1K |
|
31
Amylyx Pharmaceuticals
AMLX
$910M
| $7.46M | 0.64% |
407,205
+242,705
| +148% | +$4.44M |
|
|
ILPT
32
Industrial Logistics Properties Trust
ILPT
$407M
| $6.81M | 0.58% |
2,357,284
| – | – |
|
33
Aura Biosciences
AURA
$403M
| $6.67M | 0.57% |
743,892
-59,433
| -7% | -$533K |
|
34
DXP Enterprises
DXPE
$1.95B
| $6.29M | 0.54% |
179,987
-33,685
| -16% | -$1.18M |
|
35
Dyne Therapeutics
DYN
$2.02B
| $6.12M | 0.52% |
683,164
+90,000
| +15% | +$806K |
|
36
Reading International Class A
RDI
$33.8M
| $6.1M | 0.52% |
2,876,040
-9,474
| -0.3% | -$20.1K |
|
37
Reservoir Media
RSVR
$520M
| $6.02M | 0.51% |
+986,328
| New | +$6.02M |
|
38
eHealth
EHTH
$125M
| $5.92M | 0.51% |
800,000
| – | – |
|
39
InspireMD
NSPR
$101M
| $5.78M | 0.49% |
1,768,050
-92,355
| -5% | -$302K |
|
40
AN2 Therapeutics
ANTX
$34.4M
| $5.74M | 0.49% |
+356,789
| New | +$5.74M |
|
41
Cogent Biosciences
COGT
$1.82B
| $5.61M | 0.48% |
575,000
+510,868
| +797% | +$4.98M |
|
42
RH
RH
$4.7B
| $5.51M | 0.47% |
+20,853
| New | +$5.51M |
|
43
Cytokinetics
CYTK
$6.34B
| $5.28M | 0.45% |
179,257
| – | – |
|
44
Ventyx Biosciences
VTYX
$180M
| $5.13M | 0.44% |
147,623
-45,048
| -23% | -$1.56M |
|
45
Gossamer Bio
GOSS
$668M
| $5.07M | 0.43% |
+6,089,471
| New | +$5.07M |
|
46
Dianthus Therapeutics
DNTH
$853M
| $4.6M | 0.39% |
336,862
+24,362
| +8% | +$333K |
|
|
GMDA
47
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $4.45M | 0.38% |
+4,325,000
| New | +$4.45M |
|
48
Xtant Medical Holdings
XTNT
$82.1M
| $4.4M | 0.38% |
+4,000,000
| New | +$4.4M |
|
49
Vanda Pharmaceuticals
VNDA
$272M
| $4.32M | 0.37% |
+1,000,000
| New | +$4.32M |
|
50
ARS Pharmaceuticals
SPRY
$995M
| $4.15M | 0.35% |
1,099,075
+918,978
| +510% | +$3.47M |
|